Literature DB >> 3872958

SL12 murine T-lymphoma: a new model for tumor cell heterogeneity.

C L MacLeod, S E Weinroth, C Streifinger, S M Glaser, E F Hays.   

Abstract

It has been observed that subclones from the spontaneous murine AKR/J T-lymphoma cell line SL12 with similar in vitro growth characteristics exhibit stable differences in tumorigenicity. The cell line is composed of at least three distinct cloned cell types that are highly, moderately, or poorly tumorigenic in syngeneic host animals. When healthy, young, syngeneic host animals were given iv injections with the same number of viable growth phase cells, each cloned cell type had a different tumor incidence, latent period, and pattern of tumor spread. The unusual stability of the cloned cell lines is shown by a similar incidence, latency, and spread of the tumors when studied after more than 1 year of continuous in vitro culture. The SL12 clones also differ in several phenotypic characteristics commonly used to classify thymocyte maturation, e.g., a) the expression of three of seven surface antigens examined, b) the cellular response to glucocorticoid hormone, and c) the expression of terminal deoxynucleotidyl transferase.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3872958

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  9 in total

1.  Activated T cells express a novel gene on chromosome 8 that is closely related to the murine ecotropic retroviral receptor.

Authors:  C L MacLeod; K Finley; D Kakuda; C A Kozak; M F Wilkinson
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

2.  Negative trans-regulation of T-cell antigen receptor/T3 complex mRNA expression in murine T-lymphoma somatic cell hybrids.

Authors:  C L MacLeod; L Minning; D P Gold; C Terhorst; M Wilkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

3.  Characterization of endogenous and recombinant proviral elements of a highly tumorigenic AKR cell line.

Authors:  C Lamont; P Culp; R L Talbott; T R Phillips; R J Trauger; W N Frankel; M C Wilson; J M Coffin; J H Elder
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

4.  A mammalian arginine/lysine transporter uses multiple promoters.

Authors:  K D Finley; D K Kakuda; A Barrieux; J Kleeman; P D Huynh; C L MacLeod
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

5.  Gangliosides shed by tumor cells enhance tumor formation in mice.

Authors:  S Ladisch; S Kitada; E F Hays
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

6.  The expression of several T cell-specific and novel genes is repressed by trans-acting factors in immature T lymphoma clones.

Authors:  M F Wilkinson; J Doskow; R von Borstel; A M Fong; C L MacLeod
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

7.  Sequence analysis and expression of an X-linked, lymphocyte-regulated gene family (XLR).

Authors:  J N Siegel; C A Turner; D M Klinman; M Wilkinson; A D Steinberg; C L MacLeod; W E Paul; M M Davis; D I Cohen
Journal:  J Exp Med       Date:  1987-12-01       Impact factor: 14.307

8.  Induction of T-cell receptor-alpha and -beta mRNA in SL12 cells can occur by transcriptional and post-transcriptional mechanisms.

Authors:  M F Wilkinson; C L MacLeod
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

9.  Distinct effects of two CD44 isoforms on tumor growth in vivo.

Authors:  M S Sy; Y J Guo; I Stamenkovic
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.